Literature DB >> 9853873

Mosaicism in the inner cell mass of human blastocysts.

S Evsikov1, Y Verlinsky.   

Abstract

Although mosaicism was shown to be a normal feature in cleaving embryos, its consequences for the late preimplantation stages are unknown. We performed blastocyst immunosurgery, followed by fluorescent in-situ hybridization (FISH), to determine the number of cells and degree of mosaicism in the inner cell mass (ICM) of human blastocysts. Of 47 ICM samples analysed, 20 had aneuploid cells, and two also had a few tetraploid cells. The average degree of aneuploidy in the ICM was similar to the overall blastocyst mosaicism, suggesting that there is probably no selection for euploid ICM. The lower degree of blastocyst mosaicism, compared with the cleavage-stage embryos, may be due to a mechanism of selection against the embryos with high frequency of mosaicism, leading to elimination of these embryos prior to blastocyst formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853873     DOI: 10.1093/humrep/13.11.3151

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  21 in total

Review 1.  Tenth anniversary of preimplantation genetic diagnosis.

Authors: 
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

2.  Use of cross-species in-situ hybridization (ZOO-FISH) to assess chromosome abnormalities in day-6 in-vivo- or in-vitro-produced sheep embryos.

Authors:  Gianfranco Coppola; Basil Alexander; Dino Di Berardino; Elizabeth St John; Parvathi K Basrur; W Allan King
Journal:  Chromosome Res       Date:  2007-05-10       Impact factor: 5.239

3.  Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human.

Authors:  Michael Schmid; Claus Steinlein; Qi Tian; Amy E Hanlon Newell; Manfred Gessler; Susan B Olson; Andreas Rosenwald; Burkhard Kneitz; Lev M Fedorov
Journal:  Chromosome Res       Date:  2014-07-01       Impact factor: 5.239

4.  Higher degree of chromosome mosaicism in preimplantation embryos from carriers of robertsonian translocation t(13;14) in comparison with embryos from karyotypically normal IVF patients.

Authors:  Serena Emiliani; Eric Gonzalez-Merino; Marc Van den Bergh; Marc Abramowicz; Yvon Englert
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

5.  Pronuclear removal of tripronuclear zygotes can establish heteroparental normal karyotypic human embryonic stem cells.

Authors:  Hong-Qing Liao; Qi OuYang; Shuo-Ping Zhang; De-Hua Cheng; Guang-Xiu Lu; Ge Lin
Journal:  J Assist Reprod Genet       Date:  2016-01-04       Impact factor: 3.412

Review 6.  Human embryo mosaicism: did we drop the ball on chromosomal testing?

Authors:  Navid Esfandiari; Megan E Bunnell; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2016-08-30       Impact factor: 3.412

7.  Quantitative and qualitative trophectoderm grading allows for prediction of live birth and gender.

Authors:  Thomas Ebner; Katja Tritscher; Richard B Mayer; Peter Oppelt; Hans-Christoph Duba; Maria Maurer; Gudrun Schappacher-Tilp; Erwin Petek; Omar Shebl
Journal:  J Assist Reprod Genet       Date:  2015-11-14       Impact factor: 3.412

8.  SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts.

Authors:  L E Northrop; N R Treff; B Levy; R T Scott
Journal:  Mol Hum Reprod       Date:  2010-05-17       Impact factor: 4.025

9.  Comprehensive analysis of karyotypic mosaicism between trophectoderm and inner cell mass.

Authors:  D S Johnson; C Cinnioglu; R Ross; A Filby; G Gemelos; M Hill; A Ryan; D Smotrich; M Rabinowitz; M J Murray
Journal:  Mol Hum Reprod       Date:  2010-07-19       Impact factor: 4.025

Review 10.  Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences.

Authors:  Brittany L Daughtry; Shawn L Chavez
Journal:  Cell Tissue Res       Date:  2015-11-21       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.